1 / 24

An Evidence-Based Approach for Preventing Heart Disease

brittania
Download Presentation

An Evidence-Based Approach for Preventing Heart Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. An Evidence-Based Approach for Preventing Heart Disease Brian V. Reamy, M.D., Col, USAF, MC Professor & Chair – Dept. of Family Medicine Uniformed Services University

    2. Understand advances in how to assess a patient’s risk for cardiovascular disease Plan a treatment strategy to reduce risk Understand recent advances in prevention Objectives

    3. Introduction 2,447,910 deaths in U.S. in 2005 861,826 deaths from Cardiovascular disease 1 of every 2.8 deaths in U.S. is from CV disease AHA Heart disease & Stroke Statistics – 2008 Update. Circulation 117:e25-e146.

    4. Traditional risk factors can predict who will have CV events in 90% of all cases. HTN, Smoking, FHx, Hyperlipidemia Introduction – Prevention of CVD

    5. Background: best summary of the origins & progression of atherosclerosis: McGill et al. Preventing Heart Disease in the 21st Century: Implications of the pathobiologic determinants of atherosclerosis in youth (PDAY) study. Circulation 2008:117:1216-1227. Convergence of data from several trials over the past 4 decades has shown that ASCVD starts as early as age 2 years and progresses at a predictable rate based on your individual risk factors. Prevention - Introduction

    6. Models show that optimizing risk factors in adolescents and maintaining optimum risk status thru age 50 years could prevent 90% of ASCVD. Prevention - Introduction

    7. Primary Prevention: treatment of patients with lifestyle changes or medications before they have manifest cardiovascular disease. CVD Prevention

    8. Secondary Prevention: treatment of patients with lifestyle changes or medications after they have developed clinical CVD. CVD Prevention

    9. Older age & male gender Smoking Elevated BP Dyslipidemia Fhx of CVD in father < 55 or mother <65 yrs. Diabetes BMI > 25 OR increased waist circumference Activity level (sedentary>>>vigorous activity) Hs-CRP level and other novel serum biomarkers…. Risk Factors

    10. Patient’s who have manifest CVD are high risk Calculation of risk for all others uses risk calculators These calculators include a variety of CV risks Framingham: limitation is the lack of additive risk for age > 80 yrs or Family history http://hp2010.nhlbihin.net/atpiii/calculator.asp Reynolds Risk Score: limitations:it is used only for patients > age 45 and requires an hs-CRP level http://www.reynoldsriskscore.org/ New calculators likely coming with ATP IV Risk Calculation

    11. Risk Rarely miscalculate risk for patients at VERY-HIGH or LOW risk. Miscalculation of risk is an issue for those at intermediate risk. The hope is that enhanced incorporation of genetic risk (Fhx) & novel serum biomarkers can help to properly classify these intermediate risk patients as needing or not needing intervention.

    12. Current best sources: Primary Prevention: AHA Guidelines for Primary Prevention of Cardiovascular disease and stroke. Circulation 2002;106:388-391 Secondary Prevention: AHA/ACC Guidelines for Secondary Preventin for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation; 2006:113:2363-2372. Evidence Based Guidelines

    13. Both 1° & 2°Prevention in women: AHA Guidelines for cardiovascular disease prevention in Women Circulation; 2007;115:1481-1501 Explicit levels of evidence noted in recent guidelines following the Level I,II,III and A,B,C methodology. Evidence-Based Guidelines

    14. 1) BP 2) Lipids 3) Diet ETOH? Supplements? 4) Smoking 5) Activity 6) Weight 7) Aspirin use Develop a 7 point Prevention RX for ASCVD with each Patient

    15. Evidence-Based Guidelines: BP Diet, weight reduction, salt reduction, increase fruits & veggies, exercise, moderate etoh, medications

    16. Evidence-Based Guidelines:Lipids Start w/TLC then follow with meds in 3 – 6 mths if not at goal LDL level. Then address HDL and TG level

    17. Increase fruits and veggies Limit ETOH to <2 drinks/day men; < 1/day in women Reduce saturated fat & trans-fats Women: oily fish 2 days per week Choose whole grain high fiber foods. Evidence-Based Guidelines: Dietary Intake

    18. Walker & Reamy: Diets for Cardiovascular disease prevention. Am Fam Phy April 1, 2009 “The Mediterranean diet confers morbidity and mortality benefits in patients with known cardiovascular disease” Level A Basic components: Locally grown & minimally processed foods Plant based foods(legumes, nuts, cereals, fruits, veg) Fish & poultry w/ infrequent red meat intake Up to 4 whole eggs per week & moderate dairy intake Olive oil as principal source of fat Moderate amount of red wine with meals Eat from a colorful plate Desserts primarily of fresh fruits Evidence-Based Dietary Guidelines

    19. Ask at every visit Advise to quit every visit Assess readiness Assist in developing a plan to quit Arrange the quit plan Avoid exposure to environmental smoke at work and home Evidence Based Guidelines: Smoking – 6 “A’s”

    20. 30 minutes of moderate intensity physical activity on most and preferably all days of the week. Moderate intensity = brisk walk or 40-60% MHR Evidence-Based Guidelines: physical activity

    21. Maintain BMI 18.5 to 24.9kg/m2 Maintain waist circumference < 40” men < 35” women (measured at iliac crest horizontally) Evidence based guidelines: Weight

    22. Evidence-Based Guidelines: Aspirin doses of 75-162 mg/day are as effective as higher doses

    23. Omega-3 fatty acids (850-1000mg EPA & DHA) per day as a supplement in women with CHD (Level IIB) Screen women with CHD for depression (IIB) AVOID Hormone replacement therapy and SERM’s for 1° or 2°prevention of CVD (IIIA) Avoid antioxidant vitamin supplements (E,C, beta-carotene) & folic acid for primary or secondary prevention of CVD (IIIA) Evidence based guidelines: unique issues for women

    24. 1) BP 2) Lipids 3) Diet ETOH? Supplements? 4) Smoking 5) Activity 6) Weight 7) Aspirin use Develop a 7 point Prevention RX for ASCVD with each Patient

    25. Cases or questions?

More Related